Multiple Instance Neural Networks Based on Sparse Attention for Cancer Detection using T-cell Receptor Sequences
Younghoon Kim, Tao Wang, Danyi Xiong, Xinlei Wang, and Seongoh Park

TL;DR
This paper introduces MINN-SA, a sparse attention-based neural network for cancer detection using T-cell receptor sequences, improving accuracy and interpretability over existing methods in multiple cancer types.
Contribution
The study proposes a novel sparse attention neural network model for multiple instance learning with enhanced performance and explainability in cancer detection from TCR data.
Findings
MINN-SA achieves higher AUC scores across 10 cancer types.
The model can identify tumor-specific TCRs through attention weights.
Enhanced interpretability with effective instance selection.
Abstract
Early detection of cancers has been much explored due to its paramount importance in biomedical fields. Among different types of data used to answer this biological question, studies based on T cell receptors (TCRs) are under recent spotlight due to the growing appreciation of the roles of the host immunity system in tumor biology. However, the one-to-many correspondence between a patient and multiple TCR sequences hinders researchers from simply adopting classical statistical/machine learning methods. There were recent attempts to model this type of data in the context of multiple instance learning (MIL). Despite the novel application of MIL to cancer detection using TCR sequences and the demonstrated adequate performance in several tumor types, there is still room for improvement, especially for certain cancer types. Furthermore, explainable neural network models are not fully…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
Topicsvaccines and immunoinformatics approaches · Immunotherapy and Immune Responses · Chemokine receptors and signaling
